BORREGAARD Aktie

 

Borregaard ASA has issued a commercial paper ISIN NO0013708651 of NOK 100,000,000....

Borregaard's operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024....

15 October 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG)...

Borregaard ASA has issued a commercial paper ISIN NO0013683730 of NOK 100,000,000....

Borregaard, together with the shareholders Must Invest and Hatteland Group, will act as guarantors for a NOK 200 million convertible loan to Alginor....

The Norwegian Research Council (NFR) has awarded NOK 15 million to support Borregaard's innovation initiative, Biomer. The project aims to develop bio-based alternatives to polycarboxylates – fossil-based polymers commonly used in agriculture, industry, and household products....

Borregaard has experienced an unforeseen outage at a facility at the Sarpsborg site, which supplies a key chemical used in the production of speciality cellulose. During the period of the outage, cellulose production was restricted to grades outside standard specifications, resulting in delays of shipments of certain speciality cellulose grades....

Borregaard's Board of Directors has issued 30,000 share options in relation to the CEO appointment. Reference is made to stock exchange release on 23 May 2025....

Tom Erik Foss-Jacobsen assumed his position as Borregaard's new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025)....

Borregaard's operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and BioMaterials increased while Fine Chemicals had a lower result. Continued growth in sales to agriculture was the main reason for the improved result in BioSolutions. In BioMaterials, the result increased due to higher sales prices, improved product mix and increased sales volume, partly offset by higher wood costs. Lower sales prices for bioethanol were the main reason for the weaker result in Fine Chemicals. The net currency effects were positive in all areas....

9 July 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG)...

Borregaard ASA has issued a commercial paper ISIN NO0013597476 of NOK 100,000,000....

Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August 2025. He will also join the Group Executive Management on the same date. Bakke succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August (see stock exchange release dated 23 May 2025)....

John Arne Ulvan, member of the board of Borregaard ASA, has on 27 May 2025 purchased 2,000 shares in Borregaard ASA at a price of NOK 188.04 per share. Following this transaction, John Arne Ulvan owns 5,500 shares in Borregaard ASA. The shares are purchased at Oslo Stock Exchange....

Tom Erik Foss-Jacobsen has been appointed CEO of Borregaard ASA. He succeeds Per A. Sørlie, who will retire after 26 years in the position (see notice to Oslo Stock Exchange 3 December 2020). The appointment will be effective 1 August 2025....

Borregaard's operating revenues increased to NOK 2,036 million (NOK 1,975 million)2 in the 1st quarter of 2025. EBITDA1 reached NOK 511 million (NOK 442 million). The result in BioSolutions increased, BioMaterials had a result in line with the corresponding quarter last year and Fine Chemicals had a lower result....

23 April 2025: Borregaard ASA (”Borregaard”, OSE ticker: BRG)...

The shares in Borregaard ASA will be traded ex-dividend of NOK 4.25 per share as from today, 11 April 2025....

Das Instrument BO4 NO0010657505 BORREGAARD ASA EQUITY wird ex Dividende/Zinsen gehandelt am 11.04.2025 The instrument BO4 NO0010657505 BORREGAARD ASA EQUITY has its ex-dividend/interest day on 11.04.2025...

Borregaard ASA has issued a commercial paper ISIN NO0013536136 of NOK 200,000,000....